Related Experiment Video
Updated: May 23, 2026

ABCG5/G8 Crystallization in a Lipidic Bicelle Environment for X-Ray Crystallography
Published on: August 25, 2023
Different roles of TM5, TM6, and ECL3 in the oligomerization and function of human ABCG2
Wei Mo1, Jing Qi, Jian-Ting Zhang
1Department of Pharmacology and Toxicology and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
Abstract:
ABCG2 is a member of the ATP-binding cassette transporter superfamily, and its overexpression causes multidrug resistance (MDR) in cancer chemotherapy. ABCG2 may also protect cancer stem cells by extruding cytotoxic materials. ABCG2 has previously been shown to exist as a high-order homo-oligomer consisting of possibly 8-12 subunits, and the oligomerization domain was mapped to the C-terminal domain, including TM5, ECL3, and TM6. In this study, we further investigate this domain in detail for the role of each segment in the oligomerization and drug transport function of ABCG2 using domain swapping and site-directed mutagenesis. We found that none of the three segments (TM5, TM6, and ECL3) is essential for the oligomerization activity of ABCG2 and that any one of these three segments in the full-length context is sufficient to support ABCG2 oligomerization. While TM5 plays an important role in the drug transport function of ABCG2, TM6 and ECL3 are replaceable. Thus, each segment in the TM5-ECL3-TM6 domain plays a distinctive role in the oligomerization and function of ABCG2.
Insights
The ATP-binding cassette transporter ABCG2, implicated in multidrug resistance, forms oligomers. This study reveals TM5 is crucial for drug transport, while TM6 and ECL3 are replaceable for ABCG2 function.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- ABCG2, an ATP-binding cassette transporter, contributes to multidrug resistance (MDR) in cancer chemotherapy.
- Overexpressed ABCG2 can protect cancer stem cells by effluxing cytotoxic agents.
- ABCG2 forms high-order homo-oligomers (8-12 subunits) with the C-terminal domain (TM5, ECL3, TM6) identified as the oligomerization region.
Purpose of the Study:
- To investigate the specific roles of TM5, ECL3, and TM6 segments within the C-terminal domain of ABCG2 in protein oligomerization and drug transport.
- To elucidate the functional significance of each segment in the TM5-ECL3-TM6 domain.
Main Methods:
- Domain swapping experiments were utilized to exchange segments between different ABCG2 constructs.
- Site-directed mutagenesis was employed to introduce specific amino acid changes within the TM5, ECL3, and TM6 segments.
- Oligomerization status and drug transport activity of modified ABCG2 variants were assessed.
Main Results:
- None of the TM5, TM6, or ECL3 segments are individually essential for ABCG2 oligomerization.
- Any single segment (TM5, TM6, or ECL3) within the full-length context is sufficient to support ABCG2 oligomerization.
- TM5 is critical for ABCG2's drug transport function, whereas TM6 and ECL3 are functionally replaceable.
- Each segment within the TM5-ECL3-TM6 domain exhibits distinct roles in ABCG2 oligomerization and function.
Conclusions:
- The TM5-ECL3-TM6 domain plays a crucial role in ABCG2 oligomerization and function.
- Specific segments within this domain have differential contributions, with TM5 being vital for drug transport and TM6/ECL3 being more adaptable.
- Understanding these segment-specific roles can inform strategies to overcome ABCG2-mediated drug resistance.
More Related Videos
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
12:43Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
Published on: July 27, 2016
Related Concept Videos
ABC Transporters: Exporter
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...